Entasis Therapeutics to Present at the 39th Annual Cowen Healthcare Conference
March 06 2019 - 4:01PM
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage
biopharmaceutical company focused on the discovery and development
of novel antibacterial products, today announced that Dr. Manos
Perros, President and Chief Executive Officer, will present at the
39th Annual Cowen Healthcare Conference being held March 11-13,
2019 in Boston, Massachusetts.
Details of the presentations are below:Event:
39th Annual Cowen Healthcare ConferenceDate: March 11, 2019Time:
2:50 – 3:20 PM ET
A live webcast of the presentation can be
accessed under "Investors & Media" in the “News & Events”
section of the Company's website at www.entasistx.com. An archived
replay of the webcast will be available on its website for 30 days
after the conference.
In addition to his presentation, Dr. Perros will
be hosting 1-on-1 investor meetings at the conference. Investors
attending the conference who are interested in meeting with Company
management should contact their Cowen representatives.
About EntasisEntasis is a
clinical-stage biopharmaceutical company focused on the discovery,
development and commercialization of novel antibacterial products
to treat serious infections caused by multidrug-resistant
Gram-negative bacteria. Entasis’ targeted-design platform has
produced a pipeline of product candidates, including ETX2514SUL
(targeting A. baumannii infections), zoliflodacin (targeting
Neisseria gonorrhoeae), and ETX0282CPDP (targeting
Enterobacteriaceae infections). Entasis is also using its platform
to develop a novel class of antibiotics, non-β-lactam inhibitors of
the penicillin-binding proteins (NBPs) (targeting Gram-negative
infections). For more information, visit www.entasistx.com.
Entasis Company Contact Kyle
Dow Entasis Therapeutics (781) 810-0114 kyle.dow@entasistx.com
Investor Relations ContactLee RothThe Ruth
Group646-536-7012lroth@theruthgroup.com
Media ContactKirsten ThomasThe Ruth Group(508)
280-6592kthomas@theruthgroup.com
Entasis Therapeutics (NASDAQ:ETTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Entasis Therapeutics (NASDAQ:ETTX)
Historical Stock Chart
From Sep 2023 to Sep 2024